Skip to content

Clinical trials

Terminated Phase 2/3 trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Terminated Country / region: New Zealand Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20152
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
DiObex1
Gilead Sciences1
Intercept Pharmaceuticals1
Janssen Research & Development, LLC1
Mandos LLC1
Merck Sharp & Dohme LLC1
Reneo Pharma Ltd1
Sutro Biopharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative2
Biliary Atresia1
Carcinoma, Ovarian Epithelial1
Carcinoma, Squamous Cell1
Cognitive Dysfunction1
Deglutition Disorders1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Disease1
Fallopian Tube Neoplasms1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.